- Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy. Whelan, J.S., Davis, C.L., Rohatiner, A.Z., Leahy, M., MacCallum, P.K., Gupta, R.K., Matthews, J., Norton, A.J., Amess, J.A., Lister, T.A. Hematological oncology. (1992)